Published in Women's Health Weekly, April 1st, 2000
Osteoporosis in renal transplant recipients receiving chronic glucocorticoid immunosuppression is a significant clinical problem following transplantation. Whether glucocorticoid pharmacokinetics relates to the development of osteoporosis is unknown, noted R.J. Fountaine and colleagues
Fountaine et al. presented their research at the 2000 Annual Meeting of the American Society for Clinical Pharmacology, held March 14-18, 2000, in Los Angeles, California, USA. Their study is titled...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly